Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.602
-0.054 (-8.16%)
Nov 21, 2024, 12:24 PM EST - Market open

Ensysce Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-7.93-10.61-24.17-29.080.06-10.1
Depreciation & Amortization
---000
Other Amortization
1.520.330.951.92--
Loss (Gain) From Sale of Assets
---0---
Stock-Based Compensation
0.710.881.070.120.186.04
Other Operating Activities
0.01-0.43-1.2120.1-1.671.53
Change in Accounts Receivable
-1.680.180.16-0.440.17-0.17
Change in Accounts Payable
0.74-1.232.64-1.421.180.37
Change in Other Net Operating Assets
-1.920.112.670.56-1.171.4
Operating Cash Flow
-8.54-10.78-17.89-8.24-1.25-0.94
Sale of Property, Plant & Equipment
--0---
Investing Cash Flow
--0---
Short-Term Debt Issued
-----0.1
Long-Term Debt Issued
-1.617.5314.381.10.4
Total Debt Issued
1.611.617.5314.381.10.5
Long-Term Debt Repaid
--1.45-2-0.96--
Net Debt Issued (Repaid)
0.70.155.5313.421.10.5
Issuance of Common Stock
3.759.053.786.89--
Other Financing Activities
6.78-0.45-0.55-0-
Financing Cash Flow
11.238.768.7720.311.10.5
Net Cash Flow
2.69-2.02-9.1212.07-0.15-0.44
Free Cash Flow
-8.54-10.78-17.89-8.24-1.25-0.94
Free Cash Flow Margin
-193.16%-483.29%-708.87%-233.41%-31.73%-53.02%
Free Cash Flow Per Share
-1.32-4.76-99.42-98.10-18.13-0.94
Cash Income Tax Paid
000000
Levered Free Cash Flow
-5.46-7.42-11.19-14.66-3.27-
Unlevered Free Cash Flow
-5.97-7.53-11.36-14.57-2.65-
Change in Net Working Capital
2.911.71-2.712.281.82-
Source: S&P Capital IQ. Standard template. Financial Sources.